ROBODOC advances--historical timeline
The ROBODOC was the first robot to perform automated procedure on humans. Despite it clinical relevance and advanced features, it had not sold well enough to sustain the business of ISS. Now, with CUREXO's investment and effort, it may finally get into a competitive shape. The first concept of the new design can be seen on the right. A timeline of the V1 system development:
1986
|
Dr. Paul and Dr. Bargar develop the baseline ROBODOC concept.
| ||
05/90
|
Dr. Paul performs joint replacement surgery on canines using ROBODOC.
| ||
11/90
|
IBM invests $3M (USD) in ISS.
| ||
06/92
|
ISS development team receives prestigious Computerworld Smithsonian Award for Innovation in the Arts and Sciences for Medicine.
| ||
10/93
|
Clinical trials of the ROBODOC system begin.
| ||
10/96
|
Dr. Paul and Dr. Bargar receive the Joseph F. Engenberger Award.
| ||
11/96
|
ISS company goes public (NASDAQ, Small Cap Market).
| ||
01/97
|
ISS sells 2 ROBODOC systems to Austria.
| ||
02/97
|
ORTHODOC Pre-operative Planning software, receives FDA approval.
| ||
10/02
|
Dr. Lee's hospital in S. Korea purchases a ROBODOC system, the first in Korea. With this system, Dr. Lee's hospital becomes one of the five leading joint replacement surgery hospitals in Korea.
| ||
10/03
|
Kangdong Catholic Hospital in Korea purchases a ROBODOC system.
| ||
2004-2006
|
ISS operational hiatus period (due to lack of operating capital)
| ||
2006
|
Choennam University, Kyeoung Hee University, Ulsan Hospital, (all in S. Korea), purchase ROBODOC systems.
| ||
2006
|
Curexo Inc. purchases all ISS assets.
| ||
11/07
|
Curexo Inc. establishes CTC (Curexo Technology Corporation) and transfers all ROBODOC assets, including IP and technology, and retains major shareholder position. CTC begins re-hiring previous key ISS employees. CTC submits ROBODOC system for FDA 510(k) approval.
| ||
02/08
|
CTC receives $12M (USD) additional funds to continue operation.
| ||
08/08
|
FDA approves ROBODOC THA systems for U.S. sales under 510(k) rules.
| ||
2008
|
Curexo and IBM enter into a major patent Cross licensing agreement.
| ||
03/2009
|
Curexo receives the NSAI Certificate of Registration of Quality Management System to I.S. EN ISO 13485:2003
| ||
06/2010
|
Curexo raises $13.2 million of funding.
|
Source: Curexo
Comments